advertisement
Bacharach J 11
Showing records 1 to 11 | Display all abstracts from Bacharach J117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Bacharach J
American Journal of Ophthalmology 2024; 263: 23-34
116724 Validation of a Wearable Virtual Reality Perimeter for Glaucoma Staging, The NOVA Trial: Novel Virtual Reality Field Assessment
Bradley C
Translational vision science & technology 2024; 13: 10
117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Brubaker JW
American Journal of Ophthalmology 2024; 263: 23-34
116724 Validation of a Wearable Virtual Reality Perimeter for Glaucoma Staging, The NOVA Trial: Novel Virtual Reality Field Assessment
Ahmed IIK; Samuelson TW
Translational vision science & technology 2024; 13: 10
117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Evans DG
American Journal of Ophthalmology 2024; 263: 23-34
116724 Validation of a Wearable Virtual Reality Perimeter for Glaucoma Staging, The NOVA Trial: Novel Virtual Reality Field Assessment
Chaglasian M
Translational vision science & technology 2024; 13: 10
117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Lu F; Odani-Kawabata N
American Journal of Ophthalmology 2024; 263: 23-34
116724 Validation of a Wearable Virtual Reality Perimeter for Glaucoma Staging, The NOVA Trial: Novel Virtual Reality Field Assessment
Barnebey H; Radcliffe N
Translational vision science & technology 2024; 13: 10
117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Yamabe T
American Journal of Ophthalmology 2024; 263: 23-34
116724 Validation of a Wearable Virtual Reality Perimeter for Glaucoma Staging, The NOVA Trial: Novel Virtual Reality Field Assessment
Bacharach J
Translational vision science & technology 2024; 13: 10
117008 Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)
Wirta DL
American Journal of Ophthalmology 2024; 263: 23-34
